134 related articles for article (PubMed ID: 12150879)
1. Probes for narcotic receptor mediated phenomena. Part 28: new opioid antagonists from enantiomeric analogues of 5-(3-hydroxyphenyl)-N-phenylethylmorphan.
Hashimoto A; Jacobson AE; Rothman RB; Dersch CM; George C; Flippen-Anderson JL; Rice KC
Bioorg Med Chem; 2002 Oct; 10(10):3319-29. PubMed ID: 12150879
[TBL] [Abstract][Full Text] [Related]
2. Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series.
Hiebel AC; Lee YS; Bilsky E; Giuvelis D; Deschamps JR; Parrish DA; Aceto MD; May EL; Harris LS; Coop A; Dersch CM; Partilla JS; Rothman RB; Cheng K; Jacobson AE; Rice KC
J Med Chem; 2007 Aug; 50(16):3765-76. PubMed ID: 17625813
[TBL] [Abstract][Full Text] [Related]
3. Probes for narcotic receptor mediated phenomena. 44. Synthesis of an N-substituted 4-hydroxy-5-(3-hydroxyphenyl)morphan with high affinity and selective μ-antagonist activity.
Iyer MR; Lee YS; Deschamps JR; Dersch CM; Rothman RB; Jacobson AE; Rice KC
Eur J Med Chem; 2012 Apr; 50():44-54. PubMed ID: 22341895
[TBL] [Abstract][Full Text] [Related]
4. Modulation of opioid receptor affinity and efficacy via N-substitution of 9β-hydroxy-5-(3-hydroxyphenyl)morphan: Synthesis and computer simulation study.
Truong PM; Hassan SA; Lee YS; Kopajtic TA; Katz JL; Chadderdon AM; Traynor JR; Deschamps JR; Jacobson AE; Rice KC
Bioorg Med Chem; 2017 Apr; 25(8):2406-2422. PubMed ID: 28314512
[TBL] [Abstract][Full Text] [Related]
5. Absolute configuration and conformation of the pure opioid antagonist (+)-2,9 alpha-dimethyl-5-(m-hydroxyphenyl)morphan.
Froimowitz M; Pangborn W; Cody V
Chirality; 1992; 4(6):377-83. PubMed ID: 1449951
[TBL] [Abstract][Full Text] [Related]
6. Diaryldimethylpiperazine ligands with mu- and delta-opioid receptor affinity: Synthesis of (+)-4-[(alphaR)-alpha-(4-allyl-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide and (-)-4-[(alphaR)-alpha-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide.
Kim IJ; Ullrich T; Janetka JW; Furness MS; Jacobson AE; Rothman RB; Dersch CM; Flippen-Anderson JL; George C; Rice KC
Bioorg Med Chem; 2003 Nov; 11(22):4761-8. PubMed ID: 14556791
[TBL] [Abstract][Full Text] [Related]
7. A marked change of receptor affinity of the 2-methyl-5-(3-hydroxyphenyl)morphans upon attachment of an (E)-8-benzylidene moiety: synthesis and evaluation of a new class of sigma receptor ligands.
Bertha CM; Mattson MV; Flippen-Anderson JL; Rothman RB; Xu H; Cha XY; Becketts K; Rice KC
J Med Chem; 1994 Sep; 37(19):3163-70. PubMed ID: 7932540
[TBL] [Abstract][Full Text] [Related]
8. Opioid ligands with mixed properties from substituted enantiomeric N-phenethyl-5-phenylmorphans. Synthesis of a micro-agonist delta-antagonist and delta-inverse agonists.
Cheng K; Kim IJ; Lee MJ; Adah SA; Raymond TJ; Bilsky EJ; Aceto MD; May EL; Harris LS; Coop A; Dersch CM; Rothman RB; Jacobson AE; Rice KC
Org Biomol Chem; 2007 Apr; 5(8):1177-1190. PubMed ID: 17406716
[TBL] [Abstract][Full Text] [Related]
9. Probes for narcotic receptor-mediated phenomena. 33. Construction of a strained trans-5,6-ring system by displacement of a nitro-activated aromatic fluorine. synthesis of the penultimate oxide-bridged phenylmorphans.
Hashimoto A; Przybyl AK; Linders JT; Kodato S; Tian X; Deschamps JR; George C; Flippen-Anderson JL; Jacobson AE; Rice KC
J Org Chem; 2004 Aug; 69(16):5322-7. PubMed ID: 15287777
[TBL] [Abstract][Full Text] [Related]
10. N-substituted 4beta-methyl-5-(3-hydroxyphenyl)-7alpha-amidomorphans are potent, selective kappa opioid receptor antagonists.
Carroll FI; Melvin MS; Nuckols MC; Mascarella SW; Navarro HA; Thomas JB
J Med Chem; 2006 Mar; 49(5):1781-91. PubMed ID: 16509593
[TBL] [Abstract][Full Text] [Related]
11. A critical structural determinant of opioid receptor interaction with phenolic 5-phenylmorphans.
Kim IJ; Dersch CM; Rothman RB; Jacobson AE; Rice KC
Bioorg Med Chem; 2004 Aug; 12(16):4543-50. PubMed ID: 15265502
[TBL] [Abstract][Full Text] [Related]
12. Probes for narcotic receptor-mediated phenomena. 20. Alteration of opioid receptor subtype selectivity of the 5-(3-hydroxyphenyl)morphans by application of the message-address concept: preparation of delta-opioid receptor ligands.
Bertha CM; Flippen-Anderson JL; Rothman RB; Porreca F; Davis P; Xu H; Becketts K; Cha XY; Rice KC
J Med Chem; 1995 Apr; 38(9):1523-37. PubMed ID: 7739011
[TBL] [Abstract][Full Text] [Related]
13. N-Substituted 9beta-methyl-5-(3-hydroxyphenyl)morphans are opioid receptor pure antagonists.
Thomas JB; Zheng X; Mascarella SW; Rothman RB; Dersch CM; Partilla JS; Flippen-Anderson JL; George CF; Cantrell BE; Zimmerman DM; Carroll FI
J Med Chem; 1998 Oct; 41(21):4143-9. PubMed ID: 9767649
[TBL] [Abstract][Full Text] [Related]
14. Probes for narcotic receptor mediated phenomena. Part 42: synthesis and in vitro pharmacological characterization of the N-methyl and N-phenethyl analogues of the racemic ortho-c and para-c oxide-bridged phenylmorphans.
Kim JH; Deschamps JR; Rothman RB; Dersch CM; Folk JE; Cheng K; Jacobson AE; Rice KC
Bioorg Med Chem; 2011 Jun; 19(11):3434-43. PubMed ID: 21570305
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of Enantiomerically Pure N-Boc-Protected 1,2,3-Triaminopropylphosphonates and 1,2-Diamino-3-Hydroxypropylphosphonates.
Trocha A; Piotrowska DG; Głowacka IE
Molecules; 2019 Oct; 24(21):. PubMed ID: 31731561
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
17. Highly potent and selective phenylmorphan-based inverse agonists of the opioid delta receptor.
Thomas JB; Zhang L; Navarro HA; Carroll FI
J Med Chem; 2006 Sep; 49(18):5597-609. PubMed ID: 16942033
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro and in vivo activity of (-)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-alkenyl-, -N-alkynyl-, and -N-cyanoalkyl-5, 9-dimethyl-2'-hydroxy-6,7-benzomorphan homologues.
May EL; Jacobson AE; Mattson MV; Traynor JR; Woods JH; Harris LS; Bowman ER; Aceto MD
J Med Chem; 2000 Dec; 43(26):5030-6. PubMed ID: 11150174
[TBL] [Abstract][Full Text] [Related]
19. Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy.
McLamore S; Ullrich T; Rothman RB; Xu H; Dersch C; Coop A; Davis P; Porreca F; Jacobson AE; Rice KC
J Med Chem; 2001 Apr; 44(9):1471-4. PubMed ID: 11311071
[TBL] [Abstract][Full Text] [Related]
20. Discovery of an opioid kappa receptor selective pure antagonist from a library of N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphans.
Thomas JB; Atkinson RN; Namdev N; Rothman RB; Gigstad KM; Fix SE; Mascarella SW; Burgess JP; Vinson NA; Xu H; Dersch CM; Cantrell BE; Zimmerman DM; Carroll FI
J Med Chem; 2002 Aug; 45(16):3524-30. PubMed ID: 12139463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
